RCAG
ADAP

Rehmann Capital Advisory Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Rehmann Capital Advisory Group’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-48
Closed -$276 – 2086
2018
Q4 		$276 Hold
48
– – ﹤0.01% 1781
2018
Q3 		$650 Hold
48
– – ﹤0.01% 2046
2018
Q2 		$570 Hold
48
– – ﹤0.01% 2047
2018
Q1 		$1K Buy
+48
New +$1K ﹤0.01% 1827